Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor (original) (raw)
- Original Paper
- Published: 09 December 1998
Oncogene volume 17, pages 3045–3054 (1998)Cite this article
- 509 Accesses
- 164 Citations
- 9 Altmetric
- Metrics details
Abstract
Invasion of various carcinoma cells follows their interaction with stromal cells. Hepatocyte growth factor (HGF), four-kringle-containing growth factor, is a mesenchymal or stromal-derived mediator which affects the growth and the invasiveness of carcinoma cells. We now have evidence that a four-kringle-containing antagonist for HGF, HGF/NK4 inhibits invasion of tumors in vivo, as well as in vitro. HGF/NK4 competitively inhibited the binding of HGF to Met/HGF receptors on GB-d1 human gallbladder carcinoma cells. HGF induced invasion of the cells through Matrigel basement membrane components and into collagen gels, but HGF-induced invasion was inhibited by HGF/NK4. Invasion of GB-d1 cells was induced by co-cultivation with stromal fibroblasts, which mimics tumor-stromal interaction, but it was almost completely suppressed by HGF/NK4. Likewise, invasive growth induced by HGF in collagen gels in GB-d1 cells, HuCC-T1 human cholangiocarcinoma cells, and ME-180 human uterus cervical carcinoma cells was also strongly inhibited by HGF/NK4. When GB-d1 cells were implanted subcutaneously into nude mouse, tumor cells invaded muscular tissue, but the infusion of HGF/NK4 inhibited this invasion. Furthermore, HGF/NK4 increased apoptotic cell death of GB-d1 cells and inhibited tumor growth in vivo. These results indicate that HGF/NK4 may inhibit growth and invasion of carcinoma cells, as mediated by HGF during tumor-stromal interactions. We propose that there is a unique therapeutic potential for HGF/NK4 to prevent tumor invasion and perhaps even metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University Medical School, Suita, 565-0871, Osaka, Japan
Kazuhiko Date, Kunio Matsumoto, Keiji Kuba & Toshikazu Nakamura - Department of Surgery 1, Kyushu University Faculty of Medicine, Maidashi, 812-0054, Fukuoka, Japan
Hideo Shimura & Masao Tanaka
Authors
- Kazuhiko Date
You can also search for this author inPubMed Google Scholar - Kunio Matsumoto
You can also search for this author inPubMed Google Scholar - Keiji Kuba
You can also search for this author inPubMed Google Scholar - Hideo Shimura
You can also search for this author inPubMed Google Scholar - Masao Tanaka
You can also search for this author inPubMed Google Scholar - Toshikazu Nakamura
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Date, K., Matsumoto, K., Kuba, K. et al. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.Oncogene 17, 3045–3054 (1998). https://doi.org/10.1038/sj.onc.1202231
- Received: 10 February 1998
- Revised: 22 June 1998
- Accepted: 22 June 1998
- Published: 09 December 1998
- Issue Date: 10 December 1998
- DOI: https://doi.org/10.1038/sj.onc.1202231